XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2024
Dec. 30, 2022
Dec. 31, 2023
Mayne Pharma Agreement [Member]        
Commitments and Contingencies [Line Items]        
Cash Received For Net Working Capital     $ 12,100  
Incremental accrual for net working capital $ 2,000      
Working capital amounts       $ 5,500
Maximum [Member]        
Commitments and Contingencies [Line Items]        
Allowance for net working capital allowances remaining       5,500
Minimum [Member]        
Commitments and Contingencies [Line Items]        
Allowance for net working capital allowances remaining       $ 2,000
Chief Executive Officer [Member]        
Commitments and Contingencies [Line Items]        
Executive termination obligations   $ 56    
Paragraph IV Certification Notice Letter [Member]        
Commitments and Contingencies [Line Items]        
Legal costs   $ 2,334